Enzmann H, Zerban H, Kopp-Schneider A, Löser E, Bannach P
Institute of Toxicology, Bayer AG, Wuppertal, Germany.
Carcinogenesis. 1995 Jul;16(7):1513-8. doi: 10.1093/carcin/16.7.1513.
Male Sprague-Dawley rats received the hepatocarcinogen N-nitrosomorpholine (NNM) in the drinking water at low dose levels ranging from 6 mg/l to 60 mg/l for 6 and 12 weeks, respectively. Foci of altered hepatocytes (FAH) were demonstrated histochemically using changes in the activities of glucose-6-phosphate dehydrogenase and glycogen phosphorylase, and in the glycogen content as markers. Proliferating cells were detected by the immunohistochemical reaction for proliferating cell nuclear antigen (PCNA). The number and size of foci of altered hepatocytes increased in a time and dose-related manner. The dose-effect curves were non-linear with a slight positive slope at the low doses and a markedly increased slope at higher doses. The number of PCNA positive hepatocytes showed a dose-dependent increase. In addition to the granular distribution of PCNA in the nuclei, hepatocyte nuclei with homogeneously distributed PCNA occurred in animals exposed to 60 mg/l NNM. It is proposed that these cells are related to the occurrence of hepatocytes with higher ploidy induced by NNM and may be regarded as cells in the G2 phase of the cell cycle. The non-linear shape of the dose-response-curve of the FAH suggests that some mechanisms contribute to carcinogenesis over the whole dose range, whereas other mechanisms enhance carcinogenesis only at higher doses. The relevance of the non-linear dose-effect curve for the risk assessment of carcinogens is discussed.
雄性Sprague-Dawley大鼠分别在6毫克/升至60毫克/升的低剂量水平下饮用含肝癌致癌物N-亚硝基吗啉(NNM)的水6周和12周。利用葡萄糖-6-磷酸脱氢酶和糖原磷酸化酶的活性变化以及糖原含量作为标志物,通过组织化学方法证实了肝细胞改变灶(FAH)。通过增殖细胞核抗原(PCNA)的免疫组织化学反应检测增殖细胞。肝细胞改变灶的数量和大小呈时间和剂量依赖性增加。剂量效应曲线呈非线性,低剂量时斜率略为正,高剂量时斜率明显增加。PCNA阳性肝细胞的数量呈剂量依赖性增加。除了PCNA在细胞核中的颗粒状分布外,暴露于60毫克/升NNM的动物中还出现了PCNA均匀分布的肝细胞核。有人提出,这些细胞与NNM诱导的高倍体肝细胞的发生有关,可能被视为细胞周期G2期的细胞。FAH剂量反应曲线的非线性形状表明,在整个剂量范围内,某些机制有助于致癌作用,而其他机制仅在较高剂量时增强致癌作用。文中讨论了非线性剂量效应曲线在致癌物风险评估中的相关性。